SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Howard Henick who wrote (64)6/10/1997 7:23:00 PM
From: Miljenko Zuanic   of 656
 
Howard, and others:

Today press release for RA efficiency data from ENBREL safety trials appears very strong. Presented data are not completed. RA treatment efficiency are measured by ACR20 criterion:
1. >20% improvement in TJ/SJ count, and
2. >20% decrease in 3 of 5 other criteria.

If someone have addition data, please post on IMNX or ISIP threads.

Thanks in advance.

mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News